{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:51:37Z","timestamp":1787161897549,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170617"],"award-info":[{"award-number":["32170617"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31970558"],"award-info":[{"award-number":["31970558"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key S&T Special Projects","award":["2021YFC100530"],"award-info":[{"award-number":["2021YFC100530"]}]},{"name":"National Key S&T Special Projects","award":["2022YFC2703303"],"award-info":[{"award-number":["2022YFC2703303"]}]},{"DOI":"10.13039\/501100018540","name":"Natural Science Foundation of Guangdong Province for Distinguished Young Scholars","doi-asserted-by":"publisher","award":["2022A1515012621"],"award-info":[{"award-number":["2022A1515012621"]}],"id":[{"id":"10.13039\/501100018540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s13311-023-01429-6","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T11:02:32Z","timestamp":1697454152000},"page":"1835-1846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intravenous Administration of an AAV9 Vector Ubiquitously Expressing C1orf194 Gene Improved CMT-Like Neuropathy in C1orf194-\/- Mice"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6435-4874","authenticated-orcid":false,"given":"Zongrui","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunfei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-023-01429-6_bib1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/brain\/awg012","article-title":"Demyelinating and axonal features of Charcot\u2013Marie\u2013Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients","volume":"126","author":"Hattori","year":"2003","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01429-6_bib2","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s00415-017-8474-3","article-title":"Intermediate Charcot\u2013Marie\u2013Tooth disease: an electrophysiological reappraisal and systematic review","volume":"264","author":"Berciano","year":"2017","journal-title":"J Neurol"},{"key":"10.1007\/s13311-023-01429-6_bib3","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1093\/brain\/awz151","article-title":"Mutations in C1orf194, encoding a calcium regulator, cause dominant Charcot-Marie-Tooth disease","volume":"142","author":"Sun","year":"2019","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01429-6_bib4","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1093\/hmg\/ddaa129","article-title":"C1orf194 deficiency leads to incomplete early embryonic lethality and dominant intermediate Charcot\u2013Marie\u2013Tooth disease in a knockout mouse model","volume":"29","author":"Huang","year":"2020","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-023-01429-6_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/mus.10299","article-title":"Initial semeiology in children with Charcot-Marie-Tooth disease 1A duplication: CMT-1A Initial Semeiology","volume":"27","author":"Berciano","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1007\/s13311-023-01429-6_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1529-8027.2001.01008-6.x","article-title":"Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A","volume":"6","author":"Krajewski","year":"2001","journal-title":"J Peripher Nerv Syst"},{"key":"10.1007\/s13311-023-01429-6_bib7","series-title":"Charcot-Marie-Tooth hereditary neuropathy overview","author":"Bird","year":"2022"},{"key":"10.1007\/s13311-023-01429-6_bib8","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.3390\/ijms20143419","article-title":"Charcot-Marie-Tooth: from molecules to therapy","volume":"20","author":"Morena","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1007\/s13311-023-01429-6_bib9","first-page":"417","article-title":"Handgrip impairment in Charcot-Marie-Tooth disease","volume":"27","author":"Padua","year":"2006","journal-title":"Eura Medicophys"},{"key":"10.1007\/s13311-023-01429-6_bib10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/jns.12116","article-title":"Systematic review of exercise for Charcot-Marie-Tooth disease","volume":"20","author":"Sman","year":"2015","journal-title":"J Peripher Nerv Syst"},{"key":"10.1007\/s13311-023-01429-6_bib11","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/107110070602701125","article-title":"Orthopaedic aspects of Charcot-Marie-Tooth disease","volume":"27","author":"Guyton","year":"2006","journal-title":"Foot Ankle Int"},{"key":"10.1007\/s13311-023-01429-6_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ocl.2005.12.002","article-title":"Evaluation and treatment of hip dysplasia in Charcot-Marie-Tooth disease","volume":"37","author":"Chan","year":"2006","journal-title":"Orthop Clin North Am"},{"key":"10.1007\/s13311-023-01429-6_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003278","article-title":"Rehabilitation management of the Charcot\u2013Marie\u2013Tooth syndrome","volume":"95","author":"Corrado","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1007\/s13311-023-01429-6_bib14","first-page":"31","article-title":"Rehabilitation issues in Charcot-Marie-Tooth disease","volume":"9","author":"Kenis-Coskun","year":"2016","journal-title":"J Pediatr Rehabil Med"},{"key":"10.1007\/s13311-023-01429-6_bib15","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-023-01429-6_bib16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.omtm.2020.12.014","article-title":"Intracranial delivery of AAV9 gene therapy partially prevents retinal degeneration and visual deficits in CLN6-Batten disease mice","volume":"20","author":"White","year":"2021","journal-title":"Mol Ther - Methods Clin Dev"},{"key":"10.1007\/s13311-023-01429-6_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaneurol.2021.1272","article-title":"Five-year extension results of the phase 1 START trial of onasemnogene abeparvovec in spinal muscular atrophy","volume":"78","author":"Mendell","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1007\/s13311-023-01429-6_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaneurol.2020.1484","article-title":"Assessment of systemic delivery of rAAVrh74.MHCK7.micro-dystrophin in children with Duchenne muscular dystrophy","volume":"77","author":"Mendell","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1007\/s13311-023-01429-6_bib19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1517\/17425247.2014.871258","article-title":"The potential of adeno-associated viral vectors for gene delivery to muscle tissue","volume":"11","author":"Wang","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1007\/s13311-023-01429-6_bib20","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1089\/hum.2008.123","article-title":"Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat","volume":"19","author":"Bish","year":"2008","journal-title":"Hum Gene Ther"},{"key":"10.1007\/s13311-023-01429-6_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/jgm.1129","article-title":"AAV serotype 1 mediates more efficient gene transfer to pig myocardium than AAV serotype 2 and plasmid","volume":"10","author":"Su","year":"2008","journal-title":"J Gene Med"},{"key":"10.1007\/s13311-023-01429-6_bib22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/jns.12543","article-title":"Charcot\u2013Marie\u2013Tooth neuropathies: current gene therapy advances and the route toward translation","volume":"28","author":"Stavrou","year":"2023","journal-title":"J Peripher Nerv Syst"},{"key":"10.1007\/s13311-023-01429-6_bib23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JND-190403","article-title":"AVXS-101 (onasemnogene abeparvovec) for SMA1: comparative study with a prospective natural history cohort","volume":"6","author":"Al-Zaidy","year":"2019","journal-title":"J Neuromuscul Dis"},{"key":"10.1007\/s13311-023-01429-6_bib24","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1038\/s41467-021-22593-3","article-title":"AAV2\/9-mediated silencing of PMP22 prevents the development of pathological features in a rat model of Charcot-Marie-Tooth disease 1 A","volume":"12","author":"Gautier","year":"2021","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-023-01429-6_bib25","first-page":"130","article-title":"Targeted PMP22 TATA-box editing by CRISPR\/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice","volume":"48","author":"Lee","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1007\/s13311-023-01429-6_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-021-01839-2","article-title":"Squalenoyl siRNA PMP22 nanoparticles are effective in treating mouse models of Charcot-Marie-Tooth disease type 1 A","volume":"4","author":"Boutary","year":"2021","journal-title":"Commun Biol"},{"key":"10.1007\/s13311-023-01429-6_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.24441","article-title":"Intraneural GJB1 gene delivery improves nerve pathology in a model of X-linked Charcot\u2013Marie\u2013Tooth disease","volume":"78","author":"Sargiannidou","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-023-01429-6_bib28","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3171\/2014.6.JNS132364","article-title":"Minimally invasive convection-enhanced delivery of biologics into dorsal root ganglia: validation in the pig model and prospective modeling in humans: Technical note","volume":"121","author":"Pleticha","year":"2014","journal-title":"J Neurosurg"},{"key":"10.1007\/s13311-023-01429-6_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab252","article-title":"AAV1.NT-3 gene therapy in a CMT2D model: phenotypic improvements in GarsP278KY\/+ mice","volume":"3","author":"Ozes","year":"2021","journal-title":"Brain Commun."},{"key":"10.1007\/s13311-023-01429-6_bib30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/mt.2013.250","article-title":"AAV1.NT-3 gene therapy for Charcot\u2013Marie\u2013Tooth neuropathy","volume":"22","author":"Sahenk","year":"2014","journal-title":"Mol Ther."},{"key":"10.1007\/s13311-023-01429-6_bib31","unstructured":"Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2A - PMC. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7655101\/. (Accessed 22 Jul 2023)"},{"key":"10.1007\/s13311-023-01429-6_bib32","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1126\/science.aao1785","article-title":"Mfn2 agonists reverse mitochondrial defects in preclinical models of Charcot Marie Tooth disease type 2A","volume":"360","author":"Rocha","year":"2018","journal-title":"Science"},{"key":"10.1007\/s13311-023-01429-6_bib33","doi-asserted-by":"crossref","first-page":"e2356","DOI":"10.1212\/WNL.0000000000200325","article-title":"Randomized phase 2 study of ACE-083 in patients with Charcot-Marie-Tooth disease","volume":"98","author":"Thomas","year":"2022","journal-title":"Neurology"},{"key":"10.1007\/s13311-023-01429-6_bib35","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41434-021-00250-0","article-title":"AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy","volume":"28","author":"Kagiava","year":"2021","journal-title":"Gene Ther"},{"key":"10.1007\/s13311-023-01429-6_bib38","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1093\/hmg\/ddz199","article-title":"Gene replacement therapy after neuropathy onset provides therapeutic benefit in a model of CMT1X","volume":"28","author":"Kagiava","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-023-01429-6_bib39","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/brain\/awz064","article-title":"Gene replacement therapy in a model of Charcot-Marie-Tooth 4C neuropathy","volume":"142","author":"Schiza","year":"2019","journal-title":"Brain"},{"key":"10.1007\/s13311-023-01429-6_bib40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41434-018-0009-8","article-title":"AAV1.NT-3 gene therapy increases muscle fiber diameter through activation of mTOR pathway and metabolic remodeling in a CMT mouse model","volume":"25","author":"Yalvac","year":"2018","journal-title":"Gene Ther."},{"key":"10.1007\/s13311-023-01429-6_bib41","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0896-6273(92)90279-M","article-title":"P0 promoter directs expression of reporter and toxin genes to Schwann cells of transgenic mice","volume":"8","author":"Messing","year":"1992","journal-title":"Neuron"},{"key":"10.1007\/s13311-023-01429-6_bib42","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1523\/JNEUROSCI.3082-04.2005","article-title":"Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice","volume":"25","author":"Scherer","year":"2005","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-023-01429-6_bib43","doi-asserted-by":"crossref","first-page":"E2421","DOI":"10.1073\/pnas.1522202113","article-title":"Intrathecal gene therapy rescues a model of demyelinating peripheral neuropathy","volume":"113","author":"Kagiava","year":"2016","journal-title":"Proc Natl Acad Sci"},{"key":"10.1007\/s13311-023-01429-6_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005115","article-title":"Lack of GDAP1 induces neuronal calcium and mitochondrial defects in a knockout mouse model of Charcot-Marie-Tooth neuropathy","volume":"11","author":"Barneo-Mu\u00f1oz","year":"2015","journal-title":"PLOS Genet"},{"key":"10.1007\/s13311-023-01429-6_bib45","article-title":"Electrophysiological motor unit number estimation (MUNE) measuring compound muscle action potential (CMAP) in mouse hindlimb muscles","volume":"52899","author":"Arnold","year":"2015","journal-title":"J Vis Exp."},{"key":"10.1007\/s13311-023-01429-6_bib46","article-title":"In vivo electrophysiological measurements on mouse sciatic nerves","volume":"51181","author":"Schulz","year":"2014","journal-title":"J Vis Exp."}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01429-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-023-01429-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923020196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923020196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-023-01429-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:12:44Z","timestamp":1761808364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923020196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1878747923020196"],"URL":"https:\/\/doi.org\/10.1007\/s13311-023-01429-6","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous Administration of an AAV9 Vector Ubiquitously Expressing C1orf194 Gene Improved CMT-Like Neuropathy in C1orf194-\/- Mice","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-023-01429-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}